Educational overview only. NAD+ precursor supplements exist in a separate regulatory category from pharmaceutical compounds. This article reviews the research literature.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell, essential to hundreds of metabolic reactions. Its role in energy production, DNA repair, and cellular signaling has made it a focus of aging and longevity research for the past two decades.
NAD+ and Cellular Energy
NAD+ functions as an electron carrier in mitochondrial oxidative phosphorylation — the process by which cells generate ATP (adenosine triphosphate) from nutrients. In this role, NAD+ is continuously reduced to NADH, then re-oxidized in the electron transport chain. Without adequate NAD+ levels, mitochondrial function degrades.
Published research has consistently shown that NAD+ levels decline with age — typically by 40–60% between early adulthood and older age — across multiple tissue types in both rodent models and human samples. This decline is thought to contribute to age-associated mitochondrial dysfunction.
Sirtuins and the Longevity Connection
NAD+ is a required substrate for sirtuin enzymes (SIRT1–SIRT7), which regulate gene expression, DNA repair, and metabolic adaptation. Sirtuins became major research targets after early studies linked them to lifespan extension in model organisms. The connection to NAD+ brought intense research interest in whether restoring NAD+ levels could influence aging trajectories.
Work from David Sinclair’s lab at Harvard and Johan Auwerx’s lab at EPFL has been particularly influential, though the field is active and some early findings have been debated and refined by subsequent research.
NAD+ Precursors in Research
Because NAD+ itself is not readily absorbed by cells from circulation, research has focused on precursor compounds that can cross cell membranes and be converted to NAD+ intracellularly:
- NMN (Nicotinamide Mononucleotide) — a direct NAD+ precursor, subject of multiple human trials
- NR (Nicotinamide Riboside) — another precursor, first human bioavailability data published 2016
- Niacin (Vitamin B3) — the classic NAD+ precursor, long established as a supplement
Human Trial Data
Several phase I/II trials have examined NAD+ precursor supplementation in humans. A 2023 trial in Nature Aging reported that NMN supplementation increased blood NAD+ metabolite levels and showed improvements in muscle insulin sensitivity in older adults. Larger, longer-duration trials are ongoing. Current evidence is sufficient to establish bioavailability and short-term safety but insufficient to draw definitive conclusions about longevity outcomes in humans.
IV NAD+ Research Context
Intravenous NAD+ administration has been investigated in specific contexts, including addiction medicine (where it has been used experimentally in some clinical settings) and general wellness protocols. IV NAD+ bypasses digestive conversion but carries different risk profiles and administration requirements than oral precursor supplementation. Most IV NAD+ use occurs outside formal clinical trial settings.
The Competition for NAD+ That Rarely Gets Discussed
Sirtuins are not the only enzymes that consume NAD+, and this competition is central to understanding why NAD+ levels decline with age in the first place. PARP enzymes (poly-ADP-ribose polymerases, particularly PARP1) consume large quantities of NAD+ during DNA damage repair — and DNA damage accumulates with age, meaning PARP activity (and its NAD+ consumption) tends to rise over a lifetime. CD38, an enzyme whose expression increases with age and with chronic low-grade inflammation (“inflammaging”), is now understood to be one of the primary drivers of age-related NAD+ decline, degrading NAD+ as part of its role in immune cell signaling. In effect, sirtuins, PARPs, and CD38 are all competing for the same finite intracellular NAD+ pool — which means restoring NAD+ levels through precursor supplementation addresses only the supply side of the equation, not the increased consumption side, a distinction increasingly emphasized in more recent NAD+ research than in earlier work that focused primarily on sirtuin activation alone.
NAD+ and Mitophagy: The PINK1-Parkin Connection
Beyond its role as an electron carrier and sirtuin substrate, NAD+ availability has been linked to mitophagy — the cellular quality-control process that identifies and clears damaged mitochondria via the PINK1-Parkin pathway. Research in model organisms has reported that restoring NAD+ levels can enhance mitophagy efficiency, theoretically improving overall mitochondrial population quality over time rather than only boosting the output of existing (including damaged) mitochondria. This mitophagy angle is a genuinely distinct proposed benefit from the ATP-production and sirtuin-activation mechanisms more commonly discussed, and it remains an active and less-settled area of the NAD+ research literature.
Frequently Asked Questions
If CD38 and PARP consume NAD+, would inhibiting them be more effective than supplementing precursors?
This is an active area of research (CD38 inhibitors and PARP inhibitors both exist as investigational and, for some PARP inhibitors, approved oncology compounds), but combining consumption-inhibition with precursor supplementation, versus either approach alone, has not been definitively established as superior in human trials.
Does more NAD+ always mean healthier mitochondria?
Not necessarily in a simple linear way — NAD+’s relationship to mitochondrial quality involves multiple interacting pathways (ATP production, sirtuin activation, mitophagy), and higher levels don’t mechanically guarantee proportionally better outcomes across all of them.
Why does chronic inflammation specifically deplete NAD+?
Chronic low-grade inflammation increases CD38 expression in immune cells, and CD38 actively degrades NAD+ as part of its signaling function — meaning inflammatory conditions can accelerate NAD+ decline independent of the aging process itself.
View the NAD+ research profile on GLP1Place. Also see the NAD+ Energy Stack blend profile.
All content is for educational and informational purposes only. This is not medical advice. Consult a qualified healthcare provider before starting any supplementation protocol.
